服务热线
15339069646服务热线
15339069646| Item | Name | Cat. No. | Tag/Conjugates |
| Anti-APP mAbs [Sabirnetug Biosimilar] (MABL-5203) | MABL-5203 | ELISA, FACS, Functional assay, in vivo binding | G2, Kappa |
| Anti-TACSTD2/TROP2/EGP1 mAbs [Sacituzumab Biosimilar] (MABL-5204) | MABL-5204 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-IAP/CD47;PDL1/CD274 mAbs [Safimestomig Biosimilar] (MABL-5205) | MABL-5205 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-MOX2/CD200 mAbs [Samalizumab Biosimilar] (MABL-5206) | MABL-5206 | ELISA, FACS, Functional assay, in vivo binding | G2, Kappa |
| Anti-F3/CD142 mAbs [Samatatug Biosimilar] (MABL-5207) | MABL-5207 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-LRRC15 mAbs [Samrotamab Biosimilar] (MABL-5208) | MABL-5208 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-IL6R/CD126 mAbs [Sarilumab Biosimilar] (MABL-5209) | MABL-5209 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-PDCD1/CD279/PD1 mAbs [Sasanlimab Biosimilar] (MABL-5210) | MABL-5210 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-IL6R/CD126 mAbs [Satralizumab Biosimilar] (MABL-5211) | MABL-5211 | ELISA, FACS, Functional assay, in vivo binding | G2, Kappa |
| Anti-TAG72 mAbs [Satumomab Biosimilar] (MABL-5212) | MABL-5212 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-IL17A mAbs [Secukinumab Biosimilar] (MABL-5213) | MABL-5213 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-TNFRSF5/CD40 mAbs [Selicrelumab Biosimilar] (MABL-5214) | MABL-5214 | ELISA, FACS, Functional assay, in vivo binding | G2, Kappa |
| Anti-MAPT mAbs [Semorinemab Biosimilar] (MABL-5215) | MABL-5215 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-CD4 mAbs [Semzuvolimab Biosimilar] (MABL-5216) | MABL-5216 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-TRBV9 mAbs [Seniprutug Biosimilar] (MABL-5217) | MABL-5217 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-EGFR/ERBB1/HER1 mAbs [Serclutamab Biosimilar] (MABL-5218) | MABL-5218 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-ERBB3/HER3 mAbs [Seribantumab Biosimilar] (MABL-5219) | MABL-5219 | ELISA, FACS, Functional assay, in vivo binding | G2, Lambda |
| Anti-PDCD1/CD279/PD1 mAbs [Serplulimab Biosimilar] (MABL-5220) | MABL-5220 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-Shiga Toxin Type 2 mAbs [Setoxaximab Biosimilar] (MABL-5221) | MABL-5221 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-SOST mAbs [Setrusumab Biosimilar] (MABL-5222) | MABL-5222 | ELISA, FACS, Functional assay, in vivo binding | G2, Lambda |
联系我们
Copyright © 2012-2029 西安迈博睿（Mabioway）生物科技有限公司 版权所有
地址：陕西省西安市浐灞生态区广运潭大道南段4555号长安大学科技园4号楼A单元2层
电话：15339069646 邮箱：info@mabioway.cn